InVivo Biosystems
InVivo Biosystems enables drug discovery and development in neurological, metabolic, and rare monogenic disease indications with its premiere proprietary platform, RapidGen. RapidGen leverages -omic data and multiplexed CRISPR to speed target identification & multimodal therapeutics screening on highly relevant behavioral and molecular endpoints in vivo.
Contact Name:
Kat McCormick
Contact Email:
Website:
https://invivobiosystems.com/
City, State – Congressional District:
Eugene,
OR
–
4
Technology:
Research Tool
Funding:
Aging (NIA),
Environmental Health (NIEHS),
General Medical (NIGMS),
Genome (NHGRI),
Neurological Disorders and Stroke (NINDS),
Research Infrastructure (ORIP)
NIH Projects:
NIH RePorter for
InVivo Biosystems
Sponsored Event(s):
BIO | 2024
